Latest News

UK’s NICE recommends Novartis CAR-T Kymriah for lymphoma

The agency is recommending that the CAR-T be covered under the Cancer Drugs Fund while more data are collected. The recommendation was issued in return for a confidential discount from Novartis.

Source link

Related posts

Medical News Today: How uncontrolled inflammation leads to brain cell loss


Gene signature discovery may predict response to immune therapy


Measles Cases On The Rise: What Doctors Want You To Know


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy